Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
2021 | Bruton’s Tyrosine Kinase (BTK) Mediates Resistance to EGFR Inhibition in Non-Small-Cell Lung Carcinoma | Kuo, KT; Yeh, CT; Chen, TT; Satriyo, PB; Wang, CH; Wu, ATH; Chao, TY; Lee, KY; Hsiao, M ; Wang, LS | ONCOGENESIS 10, 56 | | | |
2017 | Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. | Lin, YC; Chao, TY; Yeh, CT; Roffler, SR; Kannagi, R; Yang, RB | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 37(1):144-155 | | | |
2019 | Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts | Chen, JH; Wu, ATH; Bamodu, OA; Yadav, VK; Chao, TY; Tzeng, YM; Mukhopadhyay, D; Hsiao, M ; Lee, JC | Cancers 12(1), 56 | | | |
2016 | Preclinical investigation of Ibrutinib, a Bruton’s kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypes | Wei, L; Su, YK; Lin, CM; Chao, TY; Huynh, TT; Jan, HJ; Whang-Peng, J; Chiou, JF; Wu, AT; Hsiao, M | Oncotarget 7(43), 69961-975 | | | |
2015 | Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma. | Lin, CS; Adebayo, BO; Wu, A; Chen, JH; Peng, YJ; Cheng, MF; Lee, WH; Hsiao, M; Chao, TY; Yeh, CT | Cancer Letters 368(1), 36-45 | | | |
2018 | Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition. | Chen, JH; Kuo, KT; Bamodu, OA; Lin, YC; Yang, RB; Yeh, CT; Chao, TY | EXPERIMENTAL CELL RESEARCH 370(2), 444-453 | | | |